BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tsui FWL, Lin A, Sari I, Zhang Z, Tsui HW, Inman RD. Serial Lipocalin 2 and Oncostatin M levels reflect inflammation status and treatment response in axial spondyloarthritis. Arthritis Res Ther 2021;23:141. [PMID: 33990221 DOI: 10.1186/s13075-021-02521-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Diaconu AD, Ceasovschih A, Șorodoc V, Pomîrleanu C, Lionte C, Șorodoc L, Ancuța C. Practical Significance of Biomarkers in Axial Spondyloarthritis: Updates on Diagnosis, Disease Activity, and Prognosis. Int J Mol Sci 2022;23. [PMID: 36232862 DOI: 10.3390/ijms231911561] [Reference Citation Analysis]
2 Tsui FWL, Lin A, Sari I, Zhang Z, Pritzker KPH, Tsui HW, Inman RD. The role of LCN2 and LCN2-MMP9 in spondylitis radiographic development: gender and HLA-B27 status differences. Arthritis Res Ther 2022;24:164. [PMID: 35804445 DOI: 10.1186/s13075-022-02854-2] [Reference Citation Analysis]
3 Cao Y, Dai Y, Zhang L, Wang D, Hu W, Yu Q, Wang X, Yu P, Liu W, Ping Y, Sun T, Sang Y, Liu Z, Chen Y, Tao Z. Combined Use of Fecal Biomarkers in Inflammatory Bowel Diseases: Oncostatin M and Calprotectin. J Inflamm Res 2021;14:6409-19. [PMID: 34880643 DOI: 10.2147/JIR.S342846] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Reveille JD. Biomarkers in axial spondyloarthritis and low back pain: a comprehensive review. Clin Rheumatol 2021. [PMID: 34674081 DOI: 10.1007/s10067-021-05968-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]